IntroductionNeurometabolic disorders remain challenging to treat, largely due to the limited availability of drugs that can cross the blood-brain barrier (BBB) and effectively target brain impairment. Key reasons for inadequate treatment include a lack of coordinated knowledge, few studies on BBB status in these diseases, and poorly designed therapies.Areas coveredThis paper provides an overview of current research on neurometabolic disorders and therapeutic options, focusing on the treatment of neurological involvement. It highlights the limitations of existing therapies, describes innovative protocols recently developed, and explores new opportunities for therapy design and testing, some of which are already under investigation. The goal is to guide researchers toward innovative and potentially more effective treatments.Expert opinionAdvancing research on neurometabolic diseases is crucial for designing effective treatment strategies. The field suffers from a lack of collaboration, and a strong collective effort is needed to enhance synergy, increase knowledge, and develop a new therapeutic paradigm for neurometabolic disorders.

Challenges and opportunities in neurometabolic disease treatment with enzyme delivery / Begley, D.; Gabathuler, R.; Pastores, G.; Garcia-Cazorla, A.; Ardigò, D.; Scarpa, M.; Tomanin, R.; Tosi, G.. - In: EXPERT OPINION ON DRUG DELIVERY. - ISSN 1742-5247. - 21:6(2024), pp. 817-828. [10.1080/17425247.2024.2375388]

Challenges and opportunities in neurometabolic disease treatment with enzyme delivery

Tosi G.
2024

Abstract

IntroductionNeurometabolic disorders remain challenging to treat, largely due to the limited availability of drugs that can cross the blood-brain barrier (BBB) and effectively target brain impairment. Key reasons for inadequate treatment include a lack of coordinated knowledge, few studies on BBB status in these diseases, and poorly designed therapies.Areas coveredThis paper provides an overview of current research on neurometabolic disorders and therapeutic options, focusing on the treatment of neurological involvement. It highlights the limitations of existing therapies, describes innovative protocols recently developed, and explores new opportunities for therapy design and testing, some of which are already under investigation. The goal is to guide researchers toward innovative and potentially more effective treatments.Expert opinionAdvancing research on neurometabolic diseases is crucial for designing effective treatment strategies. The field suffers from a lack of collaboration, and a strong collective effort is needed to enhance synergy, increase knowledge, and develop a new therapeutic paradigm for neurometabolic disorders.
2024
21
6
817
828
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery / Begley, D.; Gabathuler, R.; Pastores, G.; Garcia-Cazorla, A.; Ardigò, D.; Scarpa, M.; Tomanin, R.; Tosi, G.. - In: EXPERT OPINION ON DRUG DELIVERY. - ISSN 1742-5247. - 21:6(2024), pp. 817-828. [10.1080/17425247.2024.2375388]
Begley, D.; Gabathuler, R.; Pastores, G.; Garcia-Cazorla, A.; Ardigò, D.; Scarpa, M.; Tomanin, R.; Tosi, G.
File in questo prodotto:
File Dimensione Formato  
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery (2).pdf

Accesso riservato

Tipologia: VOR - Versione pubblicata dall'editore
Dimensione 1.41 MB
Formato Adobe PDF
1.41 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1367210
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact